Schwab US Dividend Equity ETF (SCHD) Stock Price Today
AMD expects over 80% growth in server revenue this half, excluding AI accelerator sales.
AMD CEO Lisa Su announced that the company's server revenue is projected to grow by more than 80% in the current half-year period. This growth estimate specifically excludes revenue from AMD's AI accelerator business, highlighting strong demand in ot...

Consumer Staples sector drops 1.46%, marking its worst day this month with sharp decline in stocks above 50-DMA.
The Consumer Staples sector fell 1.46% on Monday, experiencing its worst day of the month. This drop followed a shift from an overbought close to below the 50-day moving average (50-DMA), a pattern not seen since June 2020. The percentage of stocks i...

US pauses 50% tariffs on Canadian goods after reaching trade deal
President Donald Trump announced a temporary pause on the 50% tariffs scheduled to hit Canadian imports, following a trade deal agreement pending final documentation. The tariffs, set to affect about $20 billion in goods including vehicles, dairy, an...

CoreWeave draws opposing bets from top investors Tepper and Soros amid AI cloud growth and debt concerns
In Q2 2026, David Tepper's Appaloosa fund initiated a significant new position in CoreWeave, an AI cloud infrastructure company, while George Soros's fund held puts against the same stock but reduced their bearish exposure during the quarter. CoreWea...

Nuclear stocks drop as AI revenue doubts and rising long-term rates hit valuations
Nuclear energy stocks like Oklo, Constellation Energy, and NuScale Power fell sharply due to concerns over AI-related capital expenditure and a spike in long-term Treasury yields to a 19-year high. AI companies reported lower-than-expected revenue fo...

Palvella advances QTORIN for skin disorders with positive Phase 3 data and $230M funding boost
Palvella is progressing its drug QTORIN, targeting microcystic lymphatic malformations and other skin diseases, supported by positive Phase 3 SELVA trial results. The company is leveraging a repeatable regulatory and commercial platform to expand QTO...

Law firm investigates BellRing Brands officers for possible shareholder duty breaches
Halper Sadeh LLC is investigating whether certain officers and directors of BellRing Brands, Inc. breached their fiduciary duties to shareholders. Long-term BellRing stockholders may seek corporate governance reforms, financial incentives, or other r...

Apple shares rise 1.5% as Nasdaq dips, seen as safe tech amid huge off-balance-sheet AI spending by rivals
Apple shares closed up 1.5% at $310.03 while the Nasdaq-100 index fell 2%, making Apple the top performer among major tech stocks. A Wall Street Journal report revealed that big tech firms like Alphabet, Meta, and Microsoft have committed nearly $3 t...

Globant cuts 2026 revenue forecast, triggering stock drop and securities investigation.
Globant initially forecasted 2026 revenue growth but later revised its outlook to a slight year-over-year decline, causing a sharp drop in its stock price. This reversal prompted Levi & Korsinsky to investigate potential securities law violations on ...

Bicara Therapeutics advances cancer drug trial with strong cash to fund operations through 2029
Bicara Therapeutics is progressing its Phase 3 trial of ficerafusp alfa for head and neck cancer, expecting interim results by mid-2027 that could support accelerated approval. The company holds nearly $500 million in cash and securities, funding ope...

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.